/
In 2026, clinical labs will sit at the center of medicine’s personalization revolution…The most critical advances won’t just come from new assays, but from smarter use of the ones we already have, standardizing how genetic and biomarker data inform diagnosis, coverage, and care pathways
– Bill Kerr, MD
Clinical laboratories are expected to become more central to directing patient care in 2026 as advanced diagnostics, AI, and decentralized testing mature. Leaders anticipate tighter integration between labs and clinical workflows, expanded use of blood-based and multimodal biomarkers, and broader adoption of digital pathology and next-generation sequencing. As AI shifts from passive copilots to active workflow managers, improving precision in areas such as transplant diagnostics, oncology, and digital pathology, is vital to improving decision-support models without compromising data privacy and alignment with clinical evidence and patient expectations.
In this article, healthcare leaders are asked their thought on the future of AI, new diagnostics, and shifting care delivery models for 2026.
Read more at clpmag.com
